Heidary DK - Search Results

1

VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia.

Heidary DK, Huang G, Boucher D, Ma J, Forster C, Grey R, Xu J, Arnost M, Choquette D, Chen G, Zhou JH, Yao YM, Ball ED, Namchuk M, Davies RJ, Henkel G. Heidary DK, et al. J Med Chem. 2012 Jan 26;55(2):725-34. doi: 10.1021/jm201198w. Epub 2012 Jan 5. J Med Chem. 2012. PMID: 22221201

2

Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemia.

Davies RJ, Pierce AC, Forster C, Grey R, Xu J, Arnost M, Choquette D, Galullo V, Tian SK, Henkel G, Chen G, Heidary DK, Ma J, Stuver-Moody C, Namchuk M. Davies RJ, et al. Among authors: heidary dk. J Med Chem. 2011 Oct 27;54(20):7184-92. doi: 10.1021/jm200712h. Epub 2011 Oct 4. J Med Chem. 2011. PMID: 21970471

3

Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.

Heidary DK, Howerton BS, Glazer EC. Heidary DK, et al. J Med Chem. 2014 Nov 13;57(21):8936-46. doi: 10.1021/jm501043s. Epub 2014 Nov 3. J Med Chem. 2014. PMID: 25314373

4

Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.

Havrylyuk D, Howerton BS, Nease L, Parkin S, Heidary DK, Glazer EC. Havrylyuk D, et al. Among authors: heidary dk. Eur J Med Chem. 2018 Aug 5;156:790-799. doi: 10.1016/j.ejmech.2018.04.044. Epub 2018 Apr 30. Eur J Med Chem. 2018. PMID: 30055464

5

Design of Cytochrome P450 1B1 Inhibitors via a Scaffold-Hopping Approach.

Hachey AC, Fenton AD, Heidary DK, Glazer EC. Hachey AC, et al. Among authors: heidary dk. J Med Chem. 2023 Jan 12;66(1):398-412. doi: 10.1021/acs.jmedchem.2c01368. Epub 2022 Dec 15. J Med Chem. 2023. PMID: 36520541

6

Photoactive Ru(II) complexes with dioxinophenanthroline ligands are potent cytotoxic agents.

Hidayatullah AN, Wachter E, Heidary DK, Parkin S, Glazer EC. Hidayatullah AN, et al. Among authors: heidary dk. Inorg Chem. 2014 Oct 6;53(19):10030-2. doi: 10.1021/ic5017164. Epub 2014 Sep 8. Inorg Chem. 2014. PMID: 25198057

7

Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.

Kohler L, Nease L, Vo P, Garofolo J, Heidary DK, Thummel RP, Glazer EC. Kohler L, et al. Among authors: heidary dk. Inorg Chem. 2017 Oct 16;56(20):12214-12223. doi: 10.1021/acs.inorgchem.7b01642. Epub 2017 Sep 26. Inorg Chem. 2017. PMID: 28949518 Free PMC article.

8

Bis-tridentate N-Heterocyclic Carbene Ru(II) Complexes are Promising New Agents for Photodynamic Therapy.

Ryan RT, Stevens KC, Calabro R, Parkin S, Mahmoud J, Kim DY, Heidary DK, Glazer EC, Selegue JP. Ryan RT, et al. Among authors: heidary dk. Inorg Chem. 2020 Jul 6;59(13):8882-8892. doi: 10.1021/acs.inorgchem.0c00686. Epub 2020 Jun 12. Inorg Chem. 2020. PMID: 32530274

9

Strained ruthenium complexes are potent light-activated anticancer agents.

Howerton BS, Heidary DK, Glazer EC. Howerton BS, et al. Among authors: heidary dk. J Am Chem Soc. 2012 May 23;134(20):8324-7. doi: 10.1021/ja3009677. Epub 2012 May 11. J Am Chem Soc. 2012. PMID: 22553960

10

Photochemical Properties and Structure-Activity Relationships of Ru^II Complexes with Pyridylbenzazole Ligands as Promising Anticancer Agents.

Havrylyuk D, Heidary DK, Nease L, Parkin S, Glazer EC. Havrylyuk D, et al. Among authors: heidary dk. Eur J Inorg Chem. 2017 Mar 27;2017(12):1687-1694. doi: 10.1002/ejic.201601450. Epub 2017 Feb 15. Eur J Inorg Chem. 2017. PMID: 29200939 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters